Cargando…
Nanotechnology for the detection and kill of circulating tumor cells
Circulating tumor cells (CTCs) represent a surrogate biomarker of hematogenous metastases and thus could be considered as a ‘liquid biopsy’ which reveals metastasis in action. But it is absolutely a challenge to detect CTCs due to their extreme rarity. At present, the most common principle is to tak...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174536/ https://www.ncbi.nlm.nih.gov/pubmed/25258614 http://dx.doi.org/10.1186/1556-276X-9-500 |